Fidelity Investments
YDES

Fidelity Investments’s YD Bio Ltd YDES Stock Holding History

Fidelity Investments’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
1
– – ﹤0.01% 5555
2026
Q1 		$8 Hold
1
– – ﹤0.01% 5381
2025
Q4 		$12 Hold
1
– – ﹤0.01% 5371
2025
Q3 		$19 Buy
+1
New +$17 ﹤0.01% 5321

Other funds holding YDES

GWAG
Garrett Wealth Advisory Group Weatherford, Texas $651M AUM 23.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fidelity Investments's YDES Position: Q2 2026 in Review

Fidelity Investments held its YD Bio Ltd (YDES) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #5555.

Fidelity Investments first reported a position in YDES in Q3 2025 and has held it in 4 quarters since. The position peaked at $19 in Q3 2025. 12 funds tracked by Wall St. Rank hold YDES as of Q2 2026.

  • Fidelity Investments held 1 share of YD Bio Ltd worth $2 as of Q2 2026.
  • Fidelity Investments left its YD Bio Ltd share count unchanged in Q2 2026.
  • YD Bio Ltd made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5555 holding.
  • Fidelity Investments first reported a position in YD Bio Ltd in Q3 2025 and has held it in 4 quarters since.
  • Fidelity Investments's YD Bio Ltd position peaked at $19 in Q3 2025.
  • 12 funds tracked by Wall St. Rank held YD Bio Ltd as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.